Cargando…
Tackling Immune Targets for Breast Cancer: Beyond PD-1/PD-L1 Axis
The burden of breast cancer is imposing a huge global problem. Drug discovery research and novel approaches to treat breast cancer have been carried out extensively over the last decades. Although immune checkpoint inhibitors are showing promising preclinical and clinical results in treating breast...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973280/ https://www.ncbi.nlm.nih.gov/pubmed/33747948 http://dx.doi.org/10.3389/fonc.2021.628138 |